Published in Hematology Week, July 31st, 2006
According to recent research from Japan, "The present study was undertaken to evaluate the implication of delta-opioid receptor function in neurogenesis and neuroprotection.
"We found that the stimulation of delta-opioid receptors by the selective delta-opioid receptor agonist SNC80 [+-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] (10 nM) promoted neural differentiation from multipotent neural stem cells obtained from embryonic C3H mouse forebrains."
"In contrast," wrote M. Narita and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.